Goodwin Represents NueCell Bio in its Launch as a New Translational Partner for Cell Therapies
Goodwin represented NueCell Bio in connection with its formation, financing, and launch as a cell therapy science and development services company and the acquisition of assets, business operations, customer relationships, and the transition of personnel.
NueCell Bio is focused on supporting modern cell therapy programs from scientific discovery through clinical. The company is headquartered in the Sorrento Valley area of San Diego, a leading hub for biotechnology and advanced therapy development, in a state-of-the-art facility that specializes in translational services for cell therapy.
The Goodwin team included John LeClaire, John Quinn, and Ryan Peloquin.
For more information on the deal, please read the press release.